Richard Grant to Pharmacogenetics
This is a "connection" page, showing publications Richard Grant has written about Pharmacogenetics.
Connection Strength
0.301
-
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes. PLoS One. 2015; 10(3):e0121553.
Score: 0.126
-
Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testing. Expert Rev Cardiovasc Ther. 2010 Mar; 8(3):339-43.
Score: 0.089
-
The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. Diabetologia. 2009 Nov; 52(11):2299-2305.
Score: 0.086